EP Patent

EP4143188A1 — Crystalline forms of gepotidacin

Assigned to GlaxoSmithKline Intellectual Property Development Ltd · Expires 2023-03-08 · 3y expired

What this patent protects

Disclosed are novel crystalline forms of gepotidacin and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.

USPTO Abstract

Disclosed are novel crystalline forms of gepotidacin and pharmaceutical compositions containing the same. Also disclosed are processes for the preparation thereof and methods for use thereof.

Drugs covered by this patent

Patent Metadata

Patent number: EP4143188A1
Jurisdiction: EP
Classification: —
Expires: 2023-03-08
Drug substance claim: No
Drug product claim: No
Assignee: GlaxoSmithKline Intellectual Property Development Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.